$INVX
Innovex International, Inc.

2023 Q3 Form 10-Q Financial Statement

#000095017023036441 Filed on August 01, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $117.2M $89.61M
YoY Change 33.02% -4.65%
Cost Of Revenue $85.60M $65.71M
YoY Change 30.27% -5.67%
Gross Profit $31.64M $23.90M
YoY Change 41.06% -1.72%
Gross Profit Margin 26.99% 26.67%
Selling, General & Admin $26.99M $23.25M
YoY Change 20.34% 3.33%
% of Gross Profit 85.31% 97.29%
Research & Development $3.061M $3.202M
YoY Change 15.73% 17.72%
% of Gross Profit 9.67% 13.4%
Depreciation & Amortization $7.899M $7.049M
YoY Change 10.89% -8.1%
% of Gross Profit 24.96% 29.5%
Operating Expenses $26.99M $26.45M
YoY Change 20.34% 17.57%
Operating Profit -$6.071M -$2.554M
YoY Change -142.3% -33.99%
Interest Expense $1.252M $6.791M
YoY Change 855.73% 6759.6%
% of Operating Profit
Other Income/Expense, Net -$62.00K
YoY Change
Pretax Income -$3.759M $5.585M
YoY Change -125.75% -264.51%
Income Tax $3.275M $2.102M
% Of Pretax Income 37.64%
Net Earnings -$7.034M $3.483M
YoY Change -146.25% -162.53%
Net Earnings / Revenue -6.0% 3.89%
Basic Earnings Per Share -$0.21 $0.10
Diluted Earnings Per Share -$0.21 $0.10
COMMON SHARES
Basic Shares Outstanding 34.18M 34.17M
Diluted Shares Outstanding 34.13M 34.49M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $190.0M $255.3M
YoY Change -39.8% -20.42%
Cash & Equivalents $181.1M $236.5M
Short-Term Investments $8.911M $18.80M
Other Short-Term Assets $18.10M $60.72M
YoY Change -63.4% 20.54%
Inventory $183.3M $164.5M
Prepaid Expenses $19.24M $19.03M
Receivables $133.3M $274.6M
Other Receivables $0.00 $0.00
Total Short-Term Assets $709.0M $755.2M
YoY Change -4.92% 0.98%
LONG-TERM ASSETS
Property, Plant & Equipment $211.8M $191.8M
YoY Change 16.79% 6.61%
Goodwill $16.20M
YoY Change
Intangibles $42.50M $22.06M
YoY Change 78.08% -10.99%
Long-Term Investments
YoY Change
Other Assets $5.907M $10.61M
YoY Change 3.38% 80.37%
Total Long-Term Assets $298.5M $224.5M
YoY Change 32.82% -0.53%
TOTAL ASSETS
Total Short-Term Assets $709.0M $755.2M
Total Long-Term Assets $298.5M $224.5M
Total Assets $1.008B $979.7M
YoY Change 3.82% 0.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $50.46M $54.42M
YoY Change 8.54% 17.61%
Accrued Expenses $41.58M $23.04M
YoY Change 30.59% -20.29%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $106.7M $88.12M
YoY Change 19.54% 3.85%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.425M $7.621M
YoY Change 58.27% 266.22%
Total Long-Term Liabilities $3.425M $7.621M
YoY Change 58.27% 266.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $106.7M $88.12M
Total Long-Term Liabilities $3.425M $7.621M
Total Liabilities $137.1M $100.3M
YoY Change 29.73% -4.41%
SHAREHOLDERS EQUITY
Retained Earnings $948.9M $956.0M
YoY Change -0.43% 0.74%
Common Stock $98.51M $95.94M
YoY Change 11.62% 11.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $870.5M $879.4M
YoY Change
Total Liabilities & Shareholders Equity $1.008B $979.7M
YoY Change 3.82% 0.63%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$7.034M $3.483M
YoY Change -146.25% -162.53%
Depreciation, Depletion And Amortization $7.899M $7.049M
YoY Change 10.89% -8.1%
Cash From Operating Activities $23.23M $11.28M
YoY Change 2129.75% -221.56%
INVESTING ACTIVITIES
Capital Expenditures $5.430M $10.19M
YoY Change -152.81% -847.4%
Acquisitions
YoY Change
Other Investing Activities -$71.35M $906.0K
YoY Change 872.89% 142.25%
Cash From Investing Activities -$76.78M -$9.281M
YoY Change 335.84% 838.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -19.00K -11.00K
YoY Change -99.83% -99.72%
NET CHANGE
Cash From Operating Activities 23.23M 11.28M
Cash From Investing Activities -76.78M -9.281M
Cash From Financing Activities -19.00K -11.00K
Net Change In Cash -53.57M 1.990M
YoY Change 93.27% -114.06%
FREE CASH FLOW
Cash From Operating Activities $23.23M $11.28M
Capital Expenditures $5.430M $10.19M
Free Cash Flow $17.80M $1.095M
YoY Change 57.21% -113.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001042893
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Address Country
EntityAddressCountry
US
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P0Y
us-gaap Restructuring Incurred Cost Statement Of Income Or Comprehensive Income Extensible Enumeration
RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://www.dril-quip.com/20230630#RestructuringAndOtherCharges
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-13439
dei Entity Registrant Name
EntityRegistrantName
DRIL-QUIP, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
74-2162088
dei Entity Address Address Line1
EntityAddressAddressLine1
2050 West Sam Houston Parkway S.
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1100
dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77042
dei City Area Code
CityAreaCode
713
dei Local Phone Number
LocalPhoneNumber
939-7711
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
dei Trading Symbol
TradingSymbol
DRQ
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
34175449
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
236490000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
264804000
CY2023Q2 us-gaap Short Term Investments
ShortTermInvestments
18795000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
32232000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
135504000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
90861000
CY2023Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
139120000
CY2022Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
144428000
CY2023Q2 us-gaap Inventory Net
InventoryNet
164523000
CY2022Q4 us-gaap Inventory Net
InventoryNet
146004000
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
19027000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
19874000
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
30869000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
32438000
CY2023Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
10828000
CY2022Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
19383000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
755156000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
750024000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5944000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4872000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
185894000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
181270000
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
4374000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
4488000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
22061000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23348000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6237000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5949000
CY2023Q2 us-gaap Assets
Assets
979666000
CY2022Q4 us-gaap Assets
Assets
969951000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
54416000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
43019000
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
4654000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
4868000
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
6013000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
8020000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8788000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11296000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1117000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1054000
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
13136000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
19298000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
88124000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
87555000
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4512000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3756000
CY2023Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
977000
CY2022Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
823000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4919000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3807000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1725000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1658000
CY2023Q2 us-gaap Liabilities
Liabilities
100257000
CY2022Q4 us-gaap Liabilities
Liabilities
97599000
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34175449
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34175449
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34157057
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34157057
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
343000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
343000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
95593000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
90450000
us-gaap Investment Income Interest
InvestmentIncomeInterest
776000
CY2023Q2 us-gaap Interest Expense
InterestExpense
19000
CY2022Q2 us-gaap Interest Expense
InterestExpense
99000
us-gaap Interest Expense
InterestExpense
99000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
955962000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
950168000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-172489000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-168609000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
879409000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
872352000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
979666000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
969951000
CY2023Q2 us-gaap Revenues
Revenues
89607000
CY2022Q2 us-gaap Revenues
Revenues
93978000
us-gaap Revenues
Revenues
180472000
us-gaap Revenues
Revenues
177115000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
65711000
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
69663000
us-gaap Cost Of Revenue
CostOfRevenue
131213000
us-gaap Cost Of Revenue
CostOfRevenue
133658000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
23248000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22498000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
45833000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
44891000
CY2023Q2 drq Engineering And Product Development
EngineeringAndProductDevelopment
3202000
CY2022Q2 drq Engineering And Product Development
EngineeringAndProductDevelopment
2720000
drq Engineering And Product Development
EngineeringAndProductDevelopment
6601000
drq Engineering And Product Development
EngineeringAndProductDevelopment
6396000
CY2023Q2 drq Restructuring And Other Charges
RestructuringAndOtherCharges
-610000
CY2022Q2 drq Restructuring And Other Charges
RestructuringAndOtherCharges
5765000
drq Restructuring And Other Charges
RestructuringAndOtherCharges
1108000
drq Restructuring And Other Charges
RestructuringAndOtherCharges
5797000
CY2023Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
738000
CY2022Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
380000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
7385000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
494000
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
4812000
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2419000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
3692000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
3673000
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
86001000
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
97847000
us-gaap Costs And Expenses
CostsAndExpenses
173678000
us-gaap Costs And Expenses
CostsAndExpenses
186575000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
3606000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3869000
us-gaap Operating Income Loss
OperatingIncomeLoss
6794000
us-gaap Operating Income Loss
OperatingIncomeLoss
-9460000
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1998000
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
573000
us-gaap Investment Income Interest
InvestmentIncomeInterest
4825000
us-gaap Interest Expense
InterestExpense
153000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5585000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3395000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11520000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8837000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2102000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2175000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5726000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5671000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
3483000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5570000
us-gaap Net Income Loss
NetIncomeLoss
5794000
us-gaap Net Income Loss
NetIncomeLoss
-14508000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.1
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.1
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34130000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34476000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34129000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34485000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34490000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34476000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34488000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34485000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
3483000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5570000
us-gaap Net Income Loss
NetIncomeLoss
5794000
us-gaap Net Income Loss
NetIncomeLoss
-14508000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4454000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-12228000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3880000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-9342000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-971000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17798000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1914000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23850000
us-gaap Net Income Loss
NetIncomeLoss
5794000
us-gaap Net Income Loss
NetIncomeLoss
-14508000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13938000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15229000
us-gaap Share Based Compensation
ShareBasedCompensation
5143000
us-gaap Share Based Compensation
ShareBasedCompensation
5100000
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
-841000
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
5744000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
7385000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
494000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
734000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1098000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
42446000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13396000
drq Increase Decrease In Unbilled Receivable
IncreaseDecreaseInUnbilledReceivable
-6356000
drq Increase Decrease In Unbilled Receivable
IncreaseDecreaseInUnbilledReceivable
28434000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
15331000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-4663000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1652000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
11432000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-9252000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-10560000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
0
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-11000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-41638000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20209000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15611000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3429000
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
16240000
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
582000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
20462000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
33899000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
14066000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2847000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
9657000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-22000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-83000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-22000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-9740000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-720000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1871000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-28314000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-34667000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
264804000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
355451000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
236490000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
320784000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
877814000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-4454000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
3483000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-971000
CY2023Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
2566000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
879409000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
872352000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-3880000
us-gaap Net Income Loss
NetIncomeLoss
5794000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1914000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
5143000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
879409000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
887278000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-12228000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5570000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17798000
CY2022Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
157101
CY2022Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-3850000
CY2022Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
2573000
CY2022Q2 us-gaap Stockholders Equity Other
StockholdersEquityOther
-11000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
868192000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
896611000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-9342000
us-gaap Net Income Loss
NetIncomeLoss
-14508000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23850000
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
430730
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-9657000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
5100000
us-gaap Stockholders Equity Other
StockholdersEquityOther
-12000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
868192000
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2023Q1 drq Number Of Geographic Segments
NumberOfGeographicSegments
3
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:2.4%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Reclassifications</span></p><p style="text-indent:4.133%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We reclassified approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of accrued bonus related to our short-term incentive plan for the year ended December 31, 2022, from other accrued liabilities to accrued compensation to conform to our current year presentation. These reclassifications did not have an impact on our Consolidated Statements of Income (Loss), Consolidated Balance Sheets, Consolidated Statements of Comprehensive Income (Loss), Consolidated Statements of Stockholders’ Equity and Consolidated Statements of Cash Flows.</span></p>
CY2022Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
5500000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:2.4%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities as of the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates. Some of the Company’s more significant estimates are those affected by critical accounting policies for revenue recognition and asset recoverability tests and inventories</span>
CY2023Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
4200000
drq Amount To Maintain Cash Collateral Account For Letters Of Credit
AmountToMaintainCashCollateralAccountForLettersOfCredit
the outstanding letters of credit plus 5% at all times
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
360000
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
359000
CY2022Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
100000000
CY2023Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
CY2022Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
157101
CY2022Q2 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
24.49
CY2022Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3800000
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
430730
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
22.4
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
9600000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34130000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34476000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34129000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34485000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34490000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34476000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34488000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34485000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
90861000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
32438000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
750024000
CY2022Q4 us-gaap Assets
Assets
969951000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
872352000
CY2022 us-gaap Revenues
Revenues
361924000
CY2022 drq Restructuring And Other Charges
RestructuringAndOtherCharges
13364000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
454000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4703000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1624000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
47536000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
743837000
CY2022Q3 us-gaap Assets
Assets
968603000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
862916000
CY2022Q3 drq Restructuring And Other Charges
RestructuringAndOtherCharges
4101000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
12431000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12679000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
13289000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.39
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
drq Restructuring And Other Charges
RestructuringAndOtherCharges
9898000
us-gaap Operating Income Loss
OperatingIncomeLoss
2971000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3842000
us-gaap Net Income Loss
NetIncomeLoss
-1219000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
100490000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
745052000
CY2021Q4 us-gaap Assets
Assets
1009929000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
896611000
CY2021 us-gaap Revenues
Revenues
322448000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-125335000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-125547000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-128493000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.63
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.63
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
138592000
us-gaap Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
77817000
us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
82744000
CY2023Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
133665000
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
55400000
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.853
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.147
CY2023Q2 us-gaap Other Restructuring Costs
OtherRestructuringCosts
-610000
CY2022Q2 us-gaap Other Restructuring Costs
OtherRestructuringCosts
710000
us-gaap Other Restructuring Costs
OtherRestructuringCosts
1108000
us-gaap Other Restructuring Costs
OtherRestructuringCosts
710000
CY2023Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
30954000
CY2022Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
29995000
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
35328000
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
41700000
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
170140000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
150170000
CY2023Q2 us-gaap Inventory Gross
InventoryGross
236422000
CY2022Q4 us-gaap Inventory Gross
InventoryGross
221865000
CY2023Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
71899000
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
75861000
CY2023Q2 us-gaap Inventory Net
InventoryNet
164523000
CY2022Q4 us-gaap Inventory Net
InventoryNet
146004000
CY2023Q2 drq Reduction In Raw Materials By Reserve
ReductionInRawMaterialsByReserve
-8200000
CY2023Q2 drq Reduction In Work In Progress By Reserve
ReductionInWorkInProgressByReserve
-2900000
CY2023Q2 drq Reduction In Finished Goods By Reserve
ReductionInFinishedGoodsByReserve
-60800000
CY2022Q4 drq Reduction In Raw Materials By Reserve
ReductionInRawMaterialsByReserve
-8100000
CY2022Q4 drq Reduction In Work In Progress By Reserve
ReductionInWorkInProgressByReserve
-3400000
CY2022Q4 drq Reduction In Finished Goods By Reserve
ReductionInFinishedGoodsByReserve
-64400000
CY2023Q2 us-gaap Severance Costs1
SeveranceCosts1
0
CY2022Q2 us-gaap Severance Costs1
SeveranceCosts1
0
us-gaap Severance Costs1
SeveranceCosts1
0
us-gaap Severance Costs1
SeveranceCosts1
32000
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2022Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
5055000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Asset Impairment Charges
AssetImpairmentCharges
5055000
CY2023Q2 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
-610000
CY2022Q2 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
5765000
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
1108000
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
5797000
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
3802000
us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
0
us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
-645000
drq Accrued Restructuring And Other Charges
AccruedRestructuringAndOtherCharges
-2254000
CY2023Q2 us-gaap Restructuring Reserve
RestructuringReserve
903000
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
39968000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
18018000
CY2023Q2 drq Finite Lived Intangible Assets Accumulated Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsAccumulatedForeignCurrencyTranslationGainLoss
111000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
22061000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
40499000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16826000
CY2022Q4 drq Finite Lived Intangible Assets Accumulated Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsAccumulatedForeignCurrencyTranslationGainLoss
-325000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
23348000
drq Number Of Geographic Segments
NumberOfGeographicSegments
3
CY2023Q2 us-gaap Revenues
Revenues
89607000
CY2022Q2 us-gaap Revenues
Revenues
93978000
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7049000
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7670000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
3606000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3869000
us-gaap Revenues
Revenues
180472000
us-gaap Revenues
Revenues
177115000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13938000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15229000
us-gaap Operating Income Loss
OperatingIncomeLoss
6794000
us-gaap Operating Income Loss
OperatingIncomeLoss
-9460000
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.376
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.497
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.641
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.642
CY2023Q2 us-gaap Deferred Tax Liabilities Undistributed Foreign Earnings
DeferredTaxLiabilitiesUndistributedForeignEarnings
2800000
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-23-036441-index-headers.html Edgar Link pending
0000950170-23-036441-index.html Edgar Link pending
0000950170-23-036441.txt Edgar Link pending
0000950170-23-036441-xbrl.zip Edgar Link pending
drq-20230630.htm Edgar Link pending
drq-20230630.xsd Edgar Link pending
drq-ex31_1.htm Edgar Link pending
drq-ex31_2.htm Edgar Link pending
drq-ex32_1.htm Edgar Link pending
drq-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
drq-20230630_def.xml Edgar Link unprocessable
drq-20230630_lab.xml Edgar Link unprocessable
drq-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
drq-20230630_htm.xml Edgar Link completed
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
drq-20230630_cal.xml Edgar Link unprocessable